Abstracts Archive - Page 333 of 1683 - ATC Abstracts

2020 American Transplant Congress
Is the Survival Impacted by Multiple Cancer after Liver Transplantation? A Retrospective French National Multicentric Study between 1993-2013
M. Altieri
Chu Caen, Caen, France
*Purpose: Introduction: Despite the great progress made in recent decades, post-liver transplant de novo cancers is one of the leading causes of late complications and…
2020 American Transplant Congress
Maternal Peripartum Complications in Solid Organ Transplantation
R. X. Wang¹, G. S. Lee-Riddle², D. O. Walls³, D. S. Goldberg⁴, P. L. Abt²
¹Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, ²Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, ³Department of Surgery, Robert Wood Johnson University Hospital, New Brunswick, NJ, ⁴Department of Medicine, University of Miami Miller School of Medicine, Miami, FL
*Purpose: Previous studies examining pregnancy related complications after solid organ transplantation (SOT) primarily relied on voluntary registries and meta-analyses. Herein, we investigated maternal delivery outcomes…
2020 American Transplant Congress
Practice Patterns and Provider Adherence to Long Term Management Guidelines in the Post Liver Transplant (LT) Patient
F. Pradhan¹, P. Kang², A. Seetharam¹, S. Mehta¹, R. Nathan¹, M. Fallon¹, N. Patel¹
¹Department of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, AZ, ²Department of Epidemiology and Biostatistics, University of Arizona, Phoenix, AZ
*Purpose: Long-term use of immunosuppression is associated with increased risks of cardiovascular disease, chronic kidney disease, and cancer. We assessed practice patterns and provider adherence…
2020 American Transplant Congress
Early Allograft Dysfunction as a Predictor for Graft and Patient Survival after Liver Transplantation
L. I. Mazilescu, N. Selzner, G. Sapisochin, T. Reichman, M. Bhat, M. Cattral, L. Lilly, I. McGilvray, Z. Galvin, A. Ghanekar, M. Selzner
Multi Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada
*Purpose: Early allograft dysfunction (EAD) after liver transplantation has been associated with long-term reduced graft and patient survival. In this single center cohort study, we…
2020 American Transplant Congress
Stanford Integrated Psychosocial Assessment for Transplant Predicts Immunosuppression Non-Adherence after Liver Transplantation
S. Deutsch-Link¹, E. Weinberg², M. McDougal³, L. Jones⁴, T. Bitterman², M. Serper²
¹Medicine, University of Pennsylvania, Philadelphia, PA, ²Gastroenterology & Hepatology, University of Pennsylvania, Philadelphia, PA, ³Drexel University, Philadelphia, PA, ⁴PCOM, Philadelphia, PA
*Purpose: Patients with end-stage liver disease presenting for liver transplant (LT) evaluation have a high burden of psychosocial comorbidities. The Stanford Integrated Psychosocial Assessment for…
2020 American Transplant Congress
Evaluation of Leukopenia and Neutropenia Incidence, Treatment, and Clinical Response in Kidney and Liver Transplant Recipients
H. Kutzler, T. Webb, R. Cecere, D. O'Sullivan, P. Sheiner
Hartford Hospital, Hartford, CT
*Purpose: The purpose is to evaluate incidence, recurrence, therapy modifications, and complications of leukopenia and neutropenia (LN) in kidney (KTR) and liver transplant (LTR) recipients.*Methods:…
2020 American Transplant Congress
Risk Factors for Hepatic Artery Thrombosis: A Single Center Study with Multiple Surgeons
M. Fitzsimons¹, M. Bindal², J. Buggs³, D. Patino⁴, E. Rogers³, A. Kumar¹, A. Lu³
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴University of Tampa, Tampa, FL
*Purpose: Hepatic Artery Thrombosis (HAT) is an uncommon complication after liver transplant, but its occurrence can lead to significant and fatal outcomes. Our objective was…
2020 American Transplant Congress
Predictors and Outcomes of Acute Graft versus Host Disease after Liver Transplant
A. Caines¹, D. Moonka², S. Nagai³, R. Salgia²
¹Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI, ²Hepatology, Henry Ford Health System, Detroit, MI, ³Transplant Surgery, Henry Ford Health System, Detroit, MI
*Purpose: Graft-versus-Host Disease (GVHD) is a rare complication of liver transplant (LT) with an estimated incidence of 0.1-2% per year and a high mortality. There…
2020 American Transplant Congress
Twin Pregnancies after Liver Transplantation
L. A. Coscia¹, A. Yusuf¹, S. Rao², S. Constantinescu³, M. J. Moritz⁴
¹Transplant Pregnancy Registry International, Philadelphia, PA, ²Medicine, University of Virginia Heath System, Charlottesville, VA, ³Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, ⁴Surgery, Lehigh Valley Health Network, Allentown, PA
*Purpose: The purpose of this study is to describe twin pregnancy outcomes in female liver transplant recipients.*Methods: Data were collected by the Transplant Pregnancy Registry…
2020 American Transplant Congress
The Impact of Initial Alpha-Fetoprotein >100 but <1,000 ng/mL and Pre-Transplant alpha-Fetoprotein Reduction on Outcomes after Liver Transplant in Patients with Hepatocellular Carcinoma
M. L. Goldman¹, K. Zhou², J. L. Dodge¹, F. Yao¹, N. Mehta¹
¹Department of Medicine, UCSF, San Francisco, CA, ²Department of Medicine, USC, Los Angeles, CA
*Purpose: Under current UNOS policy, hepatocellular carcinoma (HCC) patients with alpha-fetoprotein (AFP) >1,000 ng/mL are required to show a reduction in AFP to 100 but